Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Skin Anarchy

E.382: Venture Capital’s Leading Lady, Tina Bou-Saba, Explains Beauty Brand Funding

03 Nov 2022

Description

Let’s ChatTina Bou-Saba is Co-Founder and Co-Managing Partner at Verity Venture Partners, an early-stage consumer-focused investment firm. Verity Venture Partners invests in purpose-driven entrepreneurs who are building the next generation of great consumer companies, including emerging brands and the technologies that enable them. Tina has been actively investing since 2016 through CXT Investments, her personal investment vehicle, with a focus on beauty, personal care, health and wellness, e-commerce, and enabling technology. Tina is a problem solver, creative and independent thinker, and trusted partner to entrepreneurs, with sharp instincts for commercial opportunities. After starting her career in investment banking at Morgan Stanley, she covered retail as an equity analyst at Sanford Bernstein and Berman Capital, and has broad knowledge of the industry from mass to specialty to e-commerce. As a member of the strategy team at Victoria’s Secret, Tina worked closely with VS leadership to commercialize new business opportunities, and led extensive quantitative and qualitative customer research. She attended Phillips Exeter Academy, Harvard College, and Harvard Business School, where she was a Baker Scholar.--- Send in a voice message: https://podcasters.spotify.com/pod/show/skincareanarchy/messageSupport this podcast: https://podcasters.spotify.com/pod/show/skincareanarchy/supportSupport the Show.Follow The Show On All Socials Using The Tag @skincareanarchy Hosted on Acast. See acast.com/privacy for more information.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.